Mark Grier

Mark Grier has extensive work experience in the field of medicinal chemistry. Mark is currently employed as the Associate Director of Medicinal Chemistry at Nurix Therapeutics. Prior to this, they served as an Associate Research Professor at Rutgers University. Mark also held positions as the Chief of Drug Discovery at Sentauri, Director of External Chemistry and Research Services at Echelon Biosciences and Frontier Scientific, Inc., and Director of Medicinal Chemistry at Echelon Biosciences, Inc. Mark Grier has also worked as a Consultant in Medicinal Chemistry at MedSyn-Consult. Furthermore, they had roles as the Director of Medicinal Chemistry at Kalyra Pharmaceuticals and as a Principal Scientist and Senior Scientist in the Medicinal Chemistry Department at Paratek Pharmaceuticals. Mark began their career as a Research Scientist at RSP Amino Acids, LLC.

Mark Grier completed their undergraduate studies in Chemistry at Iowa State University from 1988 to 1992. Mark then pursued a Ph.D. in Organic Chemistry at the University of Utah, where they graduated in 1998.